All News #Library
Biotech
Theravance Halves Headcount, Cans R&D Work After Phase 3 Fail
04 Mar 2026 //
BIOSPACE
Theravance Bio To Host Virtual Investor Event On Ampreloxetine
20 Nov 2025 //
PR NEWSWIRE
Theravance Bio to Share Ampreloxetine Data at Symposium
29 Oct 2025 //
PR NEWSWIRE
Theravance Presents YUPELRI Analyses in COPD at CHEST 2025
14 Oct 2025 //
PR NEWSWIRE
Theravance Biopharma to Attend Upcoming Investor Conference
23 Jul 2025 //
PR NEWSWIRE

Market Place
Sourcing Support